Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Barros, Edward Hsiao, Zeynep Eroglu, Shahneen Sandhu, Igor Samoylenko, Serigne Lo, Matteo S Carlino, George Au‐Yeung, Maria Gonzalez, Andrew J. Spillane, Thomas E Pennington, Kerwin F Shannon, Rony Kapoor, Elizabeth M. Burton, Hussein A. Tawbi, Rodabe N. Amaria, Christian U. Blank, João Pedreira Duprat Neto, Rafaela Brito de Paula, David E Gyorki, R.P.M. Saw, Sydney Ch'ng, Robert V. Rawson, Richard A. Scolyer, Inês Pires da Silva, Alexander C J van Akkooi, Georgina V Long, Alexander M. Menzies (2025). FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma. , 13(3), DOI: https://doi.org/10.1136/jitc-2025-011483.
Article308 days agoEfficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
Samuel Cass, Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton, Michael A. Davies, Jennifer L. McQuade, Alexander J. Lazar, Robert M. Mason, Michael Millward, Shahneen Sandhu, Chloe Khoo, Lydia Warburton, Veronica Guerra, Andrew Haydon, Helen Dearden, Alexander M. Menzies, Matteo S. Carlino, Jessica L. Smith, Peter Mollee, Melinda Burgess, Sally Mapp, Colm Keane, Victoria Atkinson, Sameer A. Parikh, Svetomir N. Markovic, Wei Ding, Timothy G. Call, Paul J. Hampel, Georgina V. Long, Jennifer A. Wargo, Alessandra Ferrajoli (2023). Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. , 34(9), DOI: https://doi.org/10.1016/j.annonc.2023.06.007.
Article308 days agoNeoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shahneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff, Robert Antdbacka, Charlotte E. Ariyan, Roland L. Bassett, Brett Carter, Adil Daud, Mark B. Faries, Leslie A. Fecher, Keith T. Flaherty, Jeffrey E. Gershenwald, Omid Hamid, Angela Hong, John M. Kirkwood, Serigne Lo, Kim Margolin, Jane L. Messina, Michael A. Postow, Helen Rizos, Merrick I. Ross, Elisa A. Rozeman, Robyn P.M. Saw, Vernon K. Sondak, Ryan J. Sullivan, Janis M. Taube, John F. Thompson, Bart A. van de Wiel, Alexander M.M. Eggermont, Michael A. Davies, Paolo A. Ascierto, Andrew J. Spillane, Alexander C.J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long, Miles C. Andrews (2019). Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. , 20(7), DOI: https://doi.org/10.1016/s1470-2045(19)30332-8.
Article308 days agoA randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L. Roland, Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka M. Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert S. Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis R. Ingram, Rohini R. Morey, Shadarra Crosby, Grace Mathew, Sheila L. B. Duncan, Cibelle Lima, Jean Yves Blay, Wolf H. Fridman, Kenna M. Shaw, Ignacio Wistuba, P. Andrew Futreal, Nadim J. Ajami, Jennifer A. Wargo, Neeta Somaiah (2024). A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. , 5(4), DOI: https://doi.org/10.1038/s43018-024-00726-z.
Article53 days agoA randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L. Roland, Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka M. Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert S. Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis R. Ingram, Rohini R. Morey, Shadarra Crosby, Grace Mathew, Sheila L. B. Duncan, Cibelle Lima, Jean Yves Blay, Wolf H. Fridman, Kenna M. Shaw, Ignacio Wistuba, P. Andrew Futreal, Nadim J. Ajami, Jennifer A. Wargo, Neeta Somaiah (2024). A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. , 5(4), DOI: https://doi.org/10.1038/s43018-024-00726-z.
Article53 days ago